Vaxart, Inc.

Total Valuation

Vaxart, Inc. carries a market capitalization of 119.81M, placing it among publicly traded companies globally. Its enterprise value stands at 90.61M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Share Statistics

Vaxart, Inc. currently has 241.41M shares outstanding.

Valuation Ratios

Vaxart, Inc. trades at a trailing price-to-earnings ratio of 3.74. The price-to-sales ratio is 0.59, and the price-to-book ratio stands at 1.78.

Enterprise Valuation

On an enterprise value basis, Vaxart, Inc. trades at an EV/EBITDA multiple of 1.99 and an EV/FCF ratio of 2.47. The EV/Sales ratio of 0.37 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 2.29 provides insight into valuation relative to core operating earnings.

Financial Position

Vaxart, Inc. maintains a current ratio of 1.60, meaning it holds 1.6x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 9.48, indicating elevated leverage, while an interest coverage ratio of 20.76 demonstrates strong ability to service its debt obligations.

Financial Efficiency

Vaxart, Inc. posts a return on equity of 66.97 and a return on invested capital of 56.32.

Taxes

Over the trailing twelve months, Vaxart, Inc. has paid 419,000.00 in income taxes, reflecting an effective tax rate of 1.07.

Stock Price Statistics

Vaxart, Inc.'s stock has gained approximately 30.26316% over the past 52 weeks. The 50-day moving average sits at 0.53, while the 200-day moving average is 0.58.

Income Statement

Over the trailing twelve months, Vaxart, Inc. generated 243.06M in revenue and converted that into 38.59M in net income, yielding earnings per share of 0.16. EBITDA reached 45.62M, while operating income came in at 39.61M.

Balance Sheet

Vaxart, Inc. holds 63.98M in cash and equivalents against 7.81M in total debt, resulting in a net debt position of -50.93M. Total book value stands at 82.37M, with working capital of 43.58M providing operational flexibility.

Cash Flow

Vaxart, Inc. produced 33.98M in operating cash flow over the past twelve months. After subtracting -601,000.00 in capital expenditures, free cash flow totaled 33.38M - equivalent to 0.14 per share.

Margins

Vaxart, Inc. operates with a gross margin of 100.00, reflecting its pricing power and cost economics. The operating margin of 16.30 and net profit margin of 15.88 provide insight into operational efficiency.

Dividends & Yields

Stock Splits

Vaxart, Inc.'s most recent stock split took place on February 14, 2018 with a 11:1 split ratio.

Scores

Vaxart, Inc. posts an Altman Z-Score of -0.39, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.